Privium Fund Management B.V. Arrowhead Pharmaceuticals, Inc. Transaction History
Privium Fund Management B.V.
- $401 Million
- Q3 2024
A detailed history of Privium Fund Management B.V. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 333,356 shares of ARWR stock, worth $6.92 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
333,356
Previous 286,936
16.18%
Holding current value
$6.92 Million
Previous $7.46 Million
13.46%
% of portfolio
1.61%
Previous 2.11%
Shares
8 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.5MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$326 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$254 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$185 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$132 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$101 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.2B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...